Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Allogene Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Allogene Therapeutics Inc. June 5, 202486.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 5, 2024 | Allogene Therapeutics Inc. | Open-market sale | −9,221 | $2.16 | $19,917 |
| Jun 5, 2024 | Allogene Therapeutics Inc. | Grant or award | +61,475 | — | — |
| May 30, 2024 | Allogene Therapeutics Inc. | Open-market sale | −11,200 | $2.34 | $26,208 |
| Jun 13, 2023 | Allogene Therapeutics Inc. | Grant or award | +74,561 | — | — |
Questions about Franz B. Humer
What boards is Franz B. Humer on?
Franz B. Humer sits on the board of Allogene Therapeutics Inc.
How long has Franz B. Humer served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.